Dermosoft Omp Ed4
Dermosoft Omp Ed4
Dermosoft Omp Ed4
21 October 2022
dermosoft® OMP
Product Data Record (PDR)
1. General Information
1.1 Supplier
Evonik Operations GmbH
Division Nutrition & Care
Business Line Care Solutions
Rellinghauser Straße 1-11
45128 Essen | Germany
[email protected]
https://www.evonik.com/personal-care
1.2 Product Description
dermosoft® OMP is in full compliance with current Cosmetic Regulation (EC) No 1223/2009.
1.2.1 Raw Material Category/Function
Multifunctionals
1.2.2 INCI Declaration
Methylpropanediol; Caprylyl Glycol; Phenylpropanol
1.2.3 Composition
This composition information serves for information of our customers only. It is neither relevant for
the composition listing according to Cosmetic Regulation (EC) No 1223/2009, nor does it reflect the
chemical composition according to the different chemical regulations in the world which is disclosed in
the table "information on ingredients/hazardous components" in the relevant parts of the respective
(Material) Safety Data Sheets.
1.2.4 Additives (e.g. Antioxidants, Preservatives)
INCI CAS No. / REACH Reg. No. EINECS / EC No. Content Function
no additives
Unless mentioned in our PDR under section 2.2 (By-Products/ Impurities) or 2.3 (CMR Substances),
no components which are listed in Annex II of the current Cosmetic Regulation (EC) No 1223/2009
are added to and are not to be expected in the above mentioned product, due to the raw materials and
the production process.
Page 1 of 6
2. Production Process
2.1 General Information on the Production Process
The product is obtained by mixing of main components.
dermoso ® OMP is produced in the absence of any animal derived material of any type. Based on the
information on the manufacturing process and production site no contamination with BSE/ TSE risk
materials is to be expected.
CITES: dermosoft® OMP is not based on raw materials from species listed in CITES appendices.
GMO Status:
not applicable (synthetic origin)
2.2 By-Product/Impurities
Below listed compound are technically unavoidable by-products or traces of unremovable impurities
(e.g. residual solvents). They are not added intentionally.
Information on potentially occuring by - products, impurities and selected substances of general
interest known to be CMR are summarized in section "2.3 CMR Substances".
Page 2 of 6
2.3 CMR Substances
According to Cosmetic Regulation (EC) No 1223/2009 the use of substances classified as CMR
(Carcinogenic, Mutagenic or Reprotoxic) substances of category 1A or 1B or 2, under Part 3 of Annex
VI to CLP Regulation (EC) No 1272/2008 in cosmetic products shall be prohibited.
Some of the CMR substances mentioned below and listed in Annex VI to CLP Regulation (EC) No
1272/2008 may be used as starting materials or solvents for the production of our cosmetic raw
materials and may require reporting under California Proposition 65 or the California Safe Cosmetics
Act, SB 484.
The presence of these substances has to be seen as non-intended and it is technically unavoidable in
good manufacturing practice. Traces of CMR substances can derive from impurities of the starting
materials or the manufacturing process.
Page 3 of 6
2.7 Substances of Very High Concern (SVHC)
The candidate list of substances of very high concern is regularly updated and published by ECHA. If
applicable, the information on the substance/s from the candidate list, contained in our product in
reportable amounts, is included in section 3 of the product related Safety Data Sheet (SDS).
2.8 Country of Origin
dermosoft® OMP is manufactured in: Germany
3. Animal Testing
We hereby confirm that we have never conducted any animal tests with our product dermoso ® OMP
nor that we have ordered such tests at third parties or third parties have conducted such tests with our
knowledge and acceptance to fulfil the requirements of Cosmetic Regulation (EC) No 1223/2009.
Therefore dermosoft® OMP is in full compliance with Cosmetic Regulation (EC) No 1223/2009.
4. Microbiological Status
Total Viable Count: max. 100 cfu/g
Pathogens*: absent/g
* Pathogens are: Enterobacteria, Pseudomonas, Enterococci, Candida albicans, Staphylococci
6. Regulatory Status
6.1 HS-Code: 382499
EU-CN-Code: 38249992
6.2 Regulatory Status (Chemical Regulations)
Europe
*) Any REACH registration no. referred to in this document covers the substance manufactured
and/or imported into the European Community by Evonik Operations GmbH (or by our affiliates or by
our EU suppliers). In case that a customer purchases material produced outside the EU which was not
imported into the EU before supply and subsequently imports that material into the EU, this is not
covered by any of our existing REACH registrations.
Page 4 of 6
Non EU - Countries/ Regions:
In the following countries the relevant authorities currently do not request pre-market approval for
cosmetic raw materials:
Page 5 of 6
7. Toxicology and Ecotoxicology
Refer to our document: "Summary of Toxicological and Ecotoxicological Data"
8. Packaging
5 kg can
800 kg (32 x 25 kg can)
800 kg (4 x 200 kg drum)
1000 kg IBC
9. Other Information
China Raw Material Submission Code: 135647-01292-8252
We emphasize that the recommended in-use concentrations provided in our technical product
documentation/guideline formulations might exceed the historical in-use concentration limits for
Rinse-Off and/or Leave-On products as given in current IECIC.
If the cosmetic product manufacturers would like to use higher ingredient concentration than the
maximum use levels on current IECIC for their products placed on China market, it is their
responsibility to demonstrate safety of those products.
This information and all further technical advice are based on our present knowledge and experience. However, it implies no
liability or other legal responsibility on our part, including with regard to existing third party intellectual property rights,
especially patent rights. In particular, no warranty, whether express or implied, or guarantee of product properties in the legal
sense is intended or implied. We reserve the right to make any changes according to technological progress or further
developments. The customer is not released from the obligation to conduct careful inspection and testing of incoming goods.
Performance of the product described herein should be verified by testing, which should be carried out only by qualified
experts in the sole responsibility of a customer. Reference to trade names used by other companies is neither a
recommendation, nor does it imply that similar products could not be used.
Page 6 of 6